124 related articles for article (PubMed ID: 33222565)
1. Severe treatment-resistant autoimmune haemolytic anaemia following ipilimumab in a patient with metastatic melanoma and CLL.
Jobson D; McCormack CJ; Hiscutt E; Tam C
Leuk Lymphoma; 2021 Apr; 62(4):992-994. PubMed ID: 33222565
[No Abstract] [Full Text] [Related]
2. A case of dual-mechanism immune-related anaemia in a patient with metastatic melanoma treated with nivolumab and ipilimumab.
Olson DJ; Rajagopal P; Tjota MY; Venkataraman G; Luke JJ; Gajewski TF
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169870
[TBL] [Abstract][Full Text] [Related]
3. Auto-immune hemolytic anemia and hemophagocytic lymphohistiocytosis as immune-related adverse event in patients with metastatic melanoma and concurrent chronic lymphocytic leukemia: a case series and literature review.
Dirven I; Vander Mijnsbrugge AS; Mignon S; Tijtgat J; Kint N; Neyns B
Melanoma Res; 2023 Aug; 33(4):338-344. PubMed ID: 37114670
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy-associated autoimmune hemolytic anemia.
Khan U; Ali F; Khurram MS; Zaka A; Hadid T
J Immunother Cancer; 2017; 5():15. PubMed ID: 28239468
[TBL] [Abstract][Full Text] [Related]
5. Ibrutinib is an effective treatment of autoimmune haemolytic anaemia in chronic lymphocytic leukaemia.
Manda S; Dunbar N; Marx-Wood CR; Danilov AV
Br J Haematol; 2015 Sep; 170(5):734-6. PubMed ID: 25716177
[No Abstract] [Full Text] [Related]
6. Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.
Herishanu Y; Levi S; Kamdjou T; Bornstein Y; Ram R; Benyamini N; Varon D; Avivi I; Perry C
Br J Haematol; 2021 Jan; 192(1):e1-e4. PubMed ID: 33095444
[No Abstract] [Full Text] [Related]
7. Cancer duplicity: a case of chronic lymphocytic leukemia and metastatic melanoma treated with Ipilimumab.
Spallone G; Ventura A; Mazzeo M; DI Raimondo C; Lombardo P; Silvaggio D; Bianchi L
Ital J Dermatol Venerol; 2021 Feb; 156(1):112-113. PubMed ID: 33084263
[No Abstract] [Full Text] [Related]
8. Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment.
Hodgson K; Ferrer G; Pereira A; Moreno C; Montserrat E
Br J Haematol; 2011 Jul; 154(1):14-22. PubMed ID: 21534942
[TBL] [Abstract][Full Text] [Related]
9. [Successful treatment with rituximab for autoimmune hemolytic anemia associated with chronic lymphocytic leukemia].
Tanaka Y; Ito Y; Yoshizawa S; Fujimoto H; Gotoh M; Tauchi T; Kimura Y; Ohyashiki K
Rinsho Ketsueki; 2013 Feb; 54(2):229-31. PubMed ID: 23470833
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia.
Rider TG; Grace RJ; Newman JA
Br J Haematol; 2016 Apr; 173(2):326-7. PubMed ID: 26195269
[No Abstract] [Full Text] [Related]
11. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
[TBL] [Abstract][Full Text] [Related]
12. The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia.
Pamuk GE; Turgut B; Demir M; Tezcan F; Vural O
Am J Hematol; 2006 Aug; 81(8):631-3. PubMed ID: 16906592
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia--response to Rider et al.
Danilov AV
Br J Haematol; 2016 Apr; 173(2):327-8. PubMed ID: 26195155
[No Abstract] [Full Text] [Related]
14. An Autoimmune Haemolytic Anaemia Secondary to Ipilimumab Treatment.
Ramos B; Gastal G; Rovere RK
Klin Onkol; 2017; 30(2):128-130. PubMed ID: 28397508
[TBL] [Abstract][Full Text] [Related]
15. Pembrolizumab-induced autoimmune haemolytic anemia in a patient with chronic lymphocytic leukaemia successfully treated with ibrutinib.
Yun NK; Alrifai T; Miller IJ; Larson ML
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34548302
[TBL] [Abstract][Full Text] [Related]
16. Treatment of a patient with HIV and metastatic melanoma with consequitive ipilimumab and nivolumab.
Tomsitz D; Hein R; Biedermann T; Kohlmeyer J
J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):e26-e28. PubMed ID: 28662283
[No Abstract] [Full Text] [Related]
17. Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
Smolej L
Leuk Res; 2007 Feb; 31(2):267; author reply 268-9. PubMed ID: 16716397
[No Abstract] [Full Text] [Related]
18. Ipilimumab/nivolumab-induced pseudolymphoma in a patient with malignant melanoma.
Ayoubi N; Haque A; Vera N; Ma S; Messina J; Khushalani N; Seminario-Vidal L
J Cutan Pathol; 2020 Apr; 47(4):390-393. PubMed ID: 31677178
[TBL] [Abstract][Full Text] [Related]
19. Complete ophthalmoplegia in Ipilmumab and Nivolumab combination treatment for metastatic melanoma.
Alnabulsi R; Hussain A; DeAngelis D
Orbit; 2018 Oct; 37(5):381-384. PubMed ID: 29381409
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune hemolytic anemia (AIHA) associated with chronic lymphocytic leukemia in the current era of targeted therapy.
Molica S; Polliack A
Leuk Res; 2016 Nov; 50():31-36. PubMed ID: 27657651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
